Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
Blood Advances
|
June 19, 2019
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
Leylah M Drusbosky, Neeraj Kumar Singh, Kimberly E Hawkins, et al.
Cancer
|
April 20, 2023
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Vu H Duong, Amy S Ruppert, Alice S Mims, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA
|
November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial
Jay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Nature
|
October 19, 2018
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell
|
July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
Blood Advances
|
June 19, 2019
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
Leylah M Drusbosky, Neeraj Kumar Singh, Kimberly E Hawkins, et al.
Cancer
|
April 20, 2023
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Vu H Duong, Amy S Ruppert, Alice S Mims, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA
|
November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial
Jay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Nature
|
October 19, 2018
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell
|
July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Page
of 14